864 results on '"Wallwiener D"'
Search Results
2. Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany
3. Selective microdochectomy after ductoscopic wire marking in women with pathological nipple discharge
4. Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
5. Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease
6. Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study
7. Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients
8. Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial
9. MEIGSʼ SYNDROME WITH ELEVATED SERUM CA125: CASE REPORT AND REVIEW OF THE LITERATURE: EP1003
10. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
11. COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
12. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
13. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression†
14. Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
15. CNS metastases in breast cancer patients: prognostic implications of tumor subtype
16. Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
17. Risk factors and survival outcome in cerebral metastatic breast cancer
18. Experiences of a multistep process with medical and psychological interventions for patients with congenital uterine aplasia to achieve motherhood: the Gothenburg–Tübingen collaboration
19. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: Recommendations for prevention and treatment
20. Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies
21. Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer
22. The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
23. CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary
24. Nodal status—its impact on prognosis in advanced ovarian cancer
25. Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine?
26. Pathological Prenatal Doppler Sonography Findings and Their Association with Neonatal Cranial Ultrasound Abnormalities in a High Risk Collective
27. How often does office hysteroscopy reveal pathology not previously noted on transvaginal ultrasound—a look at two typical reproductive endocrinology patient groups, including failed IVF–ET patients
28. TGFβ1 and SGK1-sensitive store-operated Ca2+ entry and Orai1 expression in endometrial Ishikawa cells
29. Electronic Psychooncological Screening of Cancer Patients (ePOS): Diagnostics and Clinical Pathways: ID 043
30. Ten years of successful oncologic quality assurance in certified breast centres in Germany: ID 261
31. Hsa-miR-199a-5p is functionally relevant in progression from ductal carcinoma in situ to invasive breast tumours: ID 187
32. Differentielle Expression von Transkripten und mikroRNAs während der Progression des Mammakarzinoms: ID 185
33. HER1, HER2, HER3 and HER4 - clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer: ID 016
34. Application of integrative medicine by postmenopausal breast cancer patients in the PreFace Phase IV study - a prospective, longitudinal trial: ID 270
35. The prognostic relevance of disseminated tumor cells in primary breast cancer patients - results from a large single-center study: ID 262
36. Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ: ID 327
37. Use of the BiClamp (a bipolar coagulation forceps) in gynecological surgery
38. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine
39. Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients
40. Is human chorionic gonadotropin directly involved in the regulation of human implantation?
41. Interventional fetal balloon valvuloplasty for congenital heart disease—current shortcomings and possible perspectives
42. Embolisation of uterine arteries or laparascopic uterine artery ligation as possible treatment of uterine leiomyoma
43. Tension-free vaginal tape (TVT): our modified technique—effective solutions for postoperative TVT correction
44. Improvement of endoscopically assisted neovagina: new application instruments and traction device
45. Class-specific pro-apoptotic effect of statins on human vascular endothelial cells
46. The laser diffractoscope – a new and fast system to analyse red blood cell flexibility with high accuracy
47. Effects of tibolone on human breast cancer cells and human vascular coronary cells
48. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer
49. Detection of disseminated tumor cells in patients with gynecological cancers
50. Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.